Allgens Medical Technology Co. Ltd. A
Allgens Medical Technology CO., LTD. engages in the research and development, production, and sale of biomedical materials and related medical device products in China. The company offers collagen artificial bone repair materials to agents and terminal hospitals. Its products include Tooth Shell for the treatment of oral or plastic surgery and BonGold for the treatment of orthopedic bone defect r… Read more
Allgens Medical Technology Co. Ltd. A (688613) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.001x
Based on the latest financial reports, Allgens Medical Technology Co. Ltd. A (688613) has a cash flow conversion efficiency ratio of -0.001x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-798.33K) by net assets (CN¥1.45 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Allgens Medical Technology Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Allgens Medical Technology Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Allgens Medical Technology Co. Ltd. A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Allgens Medical Technology Co. Ltd. A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PT Citra Marga Nusaphala Persada Tbk
F:J7K
|
0.018x |
|
China Aviation Oil (Singapore) Corporation Ltd
F:VZ8
|
0.107x |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705
|
0.012x |
|
Cembre S.p.A. Ord
LSE:0DXU
|
0.104x |
|
Luenmei Quantum Co Ltd
SHG:600167
|
0.009x |
|
Lindex Group
HE:LINDEX
|
-0.015x |
|
Dermapharm Holding SE
PINK:DMPHF
|
0.100x |
|
Berli Jucker PCL
BK:BJC
|
0.035x |
Annual Cash Flow Conversion Efficiency for Allgens Medical Technology Co. Ltd. A (2017–2024)
The table below shows the annual cash flow conversion efficiency of Allgens Medical Technology Co. Ltd. A from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.42 Billion | CN¥-19.60 Million | -0.014x | -137.50% |
| 2023-12-31 | CN¥1.40 Billion | CN¥51.68 Million | 0.037x | -52.17% |
| 2022-12-31 | CN¥1.33 Billion | CN¥102.05 Million | 0.077x | -24.62% |
| 2021-12-31 | CN¥1.27 Billion | CN¥129.76 Million | 0.102x | -21.58% |
| 2020-12-31 | CN¥651.68 Million | CN¥84.88 Million | 0.130x | -16.98% |
| 2019-12-31 | CN¥563.76 Million | CN¥88.45 Million | 0.157x | -11.12% |
| 2018-12-31 | CN¥451.70 Million | CN¥79.73 Million | 0.177x | +66.02% |
| 2017-12-31 | CN¥312.20 Million | CN¥33.19 Million | 0.106x | -- |